Investor Hub

Novavax is a global biotechnology company focused on developing our R&D assets and establishing partnerships to maximize the impact of our cutting-edge technology in protecting health.

Latest quarterly earnings
Download PDF
Latest investor presentation
Download PDF
Annual report
Download PDF
Latest publications
See our research
Pipeline
View our pipeline
NASDAQ:NVAX
Loading data...
Stock details
NASDAQ:NVAX
Loading data...
Stock details
Latest quarterly earnings
Download PDF
Latest investor presentation
Download PDF
Annual report
Download PDF
Latest publications
See our research
Pipeline
View our pipeline
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage
Reports & financials by fiscal year
Fiscal YearQuarterly
Earnings		Annual Reports & Proxy StatementsQuarterly Filings
2025
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Press Release
Q1
Q2
Q3
Annual Reports & Proxy Statements
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2024
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2024 Form 10-K
2023
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2023 Form 10-K
2022
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2022 Form 10-K
2021
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2021 Form 10-K
2020
Quarterly
Earnings
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2020 Form 10-K
Latest press releasesEvents & presentationsReports & financials
Reports & financials by fiscal year
Fiscal YearQuarterly
Earnings		Annual Reports & Proxy StatementsQuarterly Filings
2025
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Press Release
Q1
Q2
Q3
Annual Reports & Proxy Statements
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2024
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2024 Form 10-K
2023
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2023 Form 10-K
2022
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2022 Form 10-K
2021
Quarterly
Earnings
Earnings presentation:
Q1
Q2
Q3
Q4
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2021 Form 10-K
2020
Quarterly
Earnings
Press Release:
Q1
Q2
Q3
Q4
Annual Reports & Proxy Statements
Annual Report
Proxy Statement
Quarterly Filings
Q1-Form 10-Q
Q2-Form 10-Q
Q3-Form 10-Q
2020 Form 10-K
SEC filingsStock details & analyst coverage

Corporate governance

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.

Shareholders seeking information can contact investor relations at (240) 268-2022 or contact us.

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.

Sign up for investor updates